Results analysis from Kepler Trust Intelligence
Summary by AI BETAClose X
Schroder AsiaPacific (SDP)
09/12/2025
Results analysis from Kepler Trust Intelligence
Schroder AsiaPacific (SDP) has released its annual results for the year ending 30/09/2025, with a NAV total return of 15.7%, versus 16.8% for its benchmark and 12.3% for the peer group average. Over the longer term, the managers are notably ahead of the benchmark, with a five-year NAV TR of 37.3%, versus 31.2% for the index.
Share price returns were strong, leading to the discount to narrow over the period. There were 12.6m shares bought back in the financial year, with a further 2.7m in the period since.
Positive contributors came from stock selection. Examples include two Indian banks which outperformed a challenging market. The managers' underweight allocation to India also positively contributed. Singapore contributed positively due to stock selection and an overweight allocation.
Overall, country allocations were a headwind, largely due to China which rallied. The managers narrowed their underweight through selective additions to China, plus further in Hong Kong. The managers also narrowed their India underweight with two new holdings, as well as adding to Korea. To offset this, they have trimmed several ASEAN holdings.
Whilst not a target, revenue per share increased modestly, enabling an increase in the dividend.
Elsewhere, the board has introduced a performance-related tender offer, with the first of these commencing after the trust's continuation vote, due at the next AGM.
Outgoing Chairman James Williams commented on the region's, "strong and encouraging background position" as a result of, "healthy sovereign balance sheets and sustainable and responsible fiscal policies".
Kepler View
Managers Abbas Barkhourdar and Richard Sennitt have delivered back-to-back double digit returns for the past two financial years. Whilst this year's performance was slightly behind in relative terms, we are encouraged by the managers' ongoing positive stock selection. Similarly, the largest detractor to performance in this period has largely been a tailwind over the past five years.
The portfolio changes are pragmatic too, in our view, having added to stocks in both China and Hong Kong in response to economic stabilisation, albeit only to the highest quality companies.
Furthermore, the managers have added two new India holdings, narrowing the underweight allocation. This has capitalised on the country's period of weakness and added exposure to the attractive growth qualities of the Indian market at more compelling valuations.
Finally, the introduction of a conditional tender offer is a good demonstration of shareholder consideration, in our view. The trust has one of the widest discounts in the sector which arguably makes for an attractive entry point for investors, although the board have taken the prudent step of putting in a measure to address this. For the time being, the board has sought to manage the discount through share buybacks, which have been considerable over the past five years.
CLICK HERE TO READ THE FULL REPORT
Visit Kepler Trust Intelligence for more high quality independent investment trust research.
Important information
This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.
Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.
Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.
The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.
The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.
This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.
Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.
PLEASE SEE ALSO OUR TERMS AND CONDITIONS
Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 2 hours ago Johnson Matthey
- 3 hours ago Galliford Try
- 3 hours ago Galliford Try
- 3 hours ago Centrica
- 4 hours ago Smith & Nephew